PR Hub
20 June 2010
Generic drug makers in general are less transparent about programs to
make medicines available to people in developing countries than originator companies in Europe and the United States.
Follow us
Access to Medicine Index
|
Scheepmakersdijk 5A
|
2011 AS
|
Haarlem
|
The Netherlands
|
Phone +31 23 533 91 87
|
info@atmindex.org
|
www.accesstomedicineindex.org